Which of the following types of medications would you least expect to have adrenergic agonist properties?

Which of the following types of medications would you least expect to have adrenergic agonist properties?

• A. Antipsychotic
• B. Parkinson's medications
• C. ADHD drugs
• D. Hyperprolactinemia drugs

Answer: (A)

Adrenergic agonist properties come from drugs that directly stimulate alpha or beta adrenergic receptors or increase norepinephrine availability to do so. Treatments for ADHD are stimulants that boost norepinephrine and dopamine in the synapse, producing sympathetic, adrenergic-like effects such as increased heart rate and blood pressure. Parkinson’s medications often enhance dopaminergic signaling, which can indirectly influence autonomic tone and produce adrenergic-type responses as well. Hyperprolactinemia drugs are dopamine agonists; their primary action is on dopamine receptors to suppress prolactin, not on adrenergic receptors, so they don’t directly provide adrenergic stimulation. Antipsychotics, however, mainly block dopamine receptors and often also block alpha-adrenergic receptors, reducing adrenergic activity rather than stimulating it. Because of this blocking profile, they are least likely to have adrenergic agonist properties.

Adrenergic agonist properties come from drugs that directly stimulate alpha or beta adrenergic receptors or increase norepinephrine availability to do so. Treatments for ADHD are stimulants that boost norepinephrine and dopamine in the synapse, producing sympathetic, adrenergic-like effects such as increased heart rate and blood pressure. Parkinson’s medications often enhance dopaminergic signaling, which can indirectly influence autonomic tone and produce adrenergic-type responses as well. Hyperprolactinemia drugs are dopamine agonists; their primary action is on dopamine receptors to suppress prolactin, not on adrenergic receptors, so they don’t directly provide adrenergic stimulation. Antipsychotics, however, mainly block dopamine receptors and often also block alpha-adrenergic receptors, reducing adrenergic activity rather than stimulating it. Because of this blocking profile, they are least likely to have adrenergic agonist properties.